Healthcare - Medical - Diagnostics & Research - NASDAQ - US
$ 135.05
-5.05 %
$ 21.4 B
Market Cap
-13.55
P/E
INCOME STATEMENT
4.5 B
REVENUE
-1.07 B
OPERATING INCOME
-1.16 B
NET INCOME
EFFICIENCY
Earnings Waterfall
Illumina, Inc.
| Revenue | 4.5 B |
| Cost Of Revenue | 1.76 B |
| Gross Profit | 2.74 B |
| Operating Expenses | 3.81 B |
| Operating Income | -1.07 B |
| Other Expenses | 92 M |
| Net Income | -1.16 B |
Income Statement
Millions
| Dec-2023 | Jan-2023 | Jan-2022 | Jan-2021 | Dec-2019 | Dec-2018 | Dec-2017 | Jan-2017 | Jan-2016 | Dec-2014 | Dec-2013 | Dec-2012 | Jan-2012 | Jan-2011 | Jan-2010 | Dec-2008 | Dec-2007 | Dec-2006 | Jan-2006 | Jan-2005 | Dec-2003 | Dec-2002 | Dec-2001 | Dec-2000 | Dec-1999 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | |||||||||||||||||||||||||
| Revenue | 4 504.0 | 4 584.0 | 4 526.0 | 3 239.0 | 3 543.0 | 3 333.0 | 2 752.0 | 2 398.4 | 2 219.8 | 1 861.4 | 1 421.2 | 1 148.5 | 1 055.5 | 902.7 | 666.3 | 573.2 | 366.8 | 184.6 | 73.5 | 50.6 | 28.0 | 10.0 | 2.5 | 1.3 | 0.5 |
| GROSS PROFIT | |||||||||||||||||||||||||
| Cost Of Revenue | 1 760.0 | 1 612.0 | 1 372.0 | 1 036.0 | 1 076.0 | 1 033.0 | 926.0 | 731.9 | 670.5 | 563.6 | 509.3 | 375.0 | 346.4 | 301.2 | 205.8 | 205.6 | 132.4 | 59.3 | 23.2 | 13.3 | 10.0 | 3.5 | 0.6 | (0.4) | 96.4 K |
| Gross Profit | 2 744.0 | 2 972.0 | 3 154.0 | 2 203.0 | 2 467.0 | 2 300.0 | 1 826.0 | 1 666.4 | 1 549.3 | 1 297.7 | 911.9 | 773.5 | 709.1 | 601.5 | 460.6 | 367.6 | 234.4 | 125.2 | 50.3 | 37.3 | 18.0 | 6.5 | 1.9 | 1.7 | 0.6 |
| OPERATING INCOME | |||||||||||||||||||||||||
| Operating Expenses | 3 813.0 | 2 618.0 | 3 277.0 | 1 623.0 | 1 482.0 | 1 417.0 | 1 220.0 | 1 087.4 | 926.2 | 854.3 | 657.8 | 517.0 | 500.6 | 389.9 | 323.6 | 262.5 | 232.2 | 87.4 | 56.0 | 42.8 | 44.6 | 48.4 | 32.2 | 24.9 | 6.5 |
| Selling, General and Administrative Expenses | 1 612.0 | 1 297.0 | 2 092.0 | 941.0 | 835.0 | 794.0 | 674.0 | 583.0 | 524.7 | 466.3 | 381.0 | 286.0 | 303.7 | 221.0 | 176.3 | 148.0 | 101.3 | 54.1 | 28.0 | 25.1 | 18.9 | 9.1 | 5.7 | 4.2 | 1.3 |
| Research and Development Expenses | 1 354.0 | 1 321.0 | 1 185.0 | 682.0 | 647.0 | 623.0 | 546.0 | 504.4 | 401.5 | 388.1 | 276.7 | 231.0 | 196.9 | 177.9 | 140.6 | 100.0 | 73.9 | 33.4 | 27.7 | 21.1 | 22.5 | 26.8 | 20.7 | 13.6 | 4.1 |
| Operating Income | (1 069.0) | (4 179.0) | (123.0) | 580.0 | 985.0 | 883.0 | 606.0 | 587.0 | 612.8 | 514.7 | 134.1 | 200.8 | 199.5 | 211.7 | 125.6 | 80.5 | (301.2) | 37.8 | (21.4) | (5.5) | (26.6) | (41.9) | (30.3) | (23.2) | (5.9) |
| PRE-TAX INCOME | |||||||||||||||||||||||||
| Interest Income Expense | 77.0 | 26.0 | 61.0 | 49.0 | 52.0 | 57.0 | 37.0 | 33.2 | 42.1 | 41.7 | 39.7 | 37.8 | 34.8 | 24.6 | 23.7 | 42.9 | 648.9 | (4.8) | 15.8 | (4.2) | 0.8 | 8.1 | 0 | 0 | 0 |
| Total Other Income | (48.0) | (157.0) | 1 007.0 | 276.0 | 133.0 | 11.0 | 437.0 | (26.0) | (29.9) | (66.0) | 25.2 | 21.9 | (78.6) | (26.3) | (11.5) | 10.4 | 12.4 | 4.8 | (0.7) | (0.7) | (0.4) | 1.5 | 5.5 | 0 | 0 |
| Pre-Tax Income | (1 117.0) | (4 336.0) | 884.0 | 856.0 | 1 118.0 | 894.0 | 1 043.0 | 561.2 | 583.1 | 448.8 | 159.3 | 222.6 | 133.0 | 185.4 | 114.1 | 90.9 | (288.8) | 42.6 | (5.6) | (1.3) | (27.4) | (49.9) | (24.8) | 0 | 0 |
| NET INCOME | |||||||||||||||||||||||||
| Tax Provision | 44.0 | 68.0 | 122.0 | 200.0 | 128.0 | 112.0 | 365.0 | 133.1 | 125.8 | 95.4 | 34.0 | 71.4 | 46.4 | 60.5 | 41.8 | 40.4 | (10.4) | 2.7 | 31.0 | (3.5) | 1.2 | 6.5 | (5.5) | (4.6) | (0.4) |
| Net Income | (1 161.0) | (4 404.0) | 762.0 | 656.0 | 1 002.0 | 826.0 | 726.0 | 462.6 | 461.6 | 353.4 | 125.3 | 151.3 | 86.6 | 124.9 | 72.3 | 50.5 | (278.4) | 40.0 | (20.9) | (6.2) | (27.1) | (40.3) | (24.8) | (18.6) | (5.5) |
| EPS | 7.35 | 28.1 | 5.08 | 4.46 | 6.82 | 5.62 | 4.97 | 3.15 | 3.18 | 2.61 | 1 | 1.23 | 0.7 | 1.01 | 0.59 | 0.43 | 2.57 | 0.45 | 0.26 | 0.0868 | 0.42 | 0.65 | 0.42 | 0.69 | 1.96 |